用户 drawsign61

已登录: 23 小时 (从 5月 9)
类型: 已注册用户
全名:
位置:
网站: https://www.selleckchem.com/products/kpt-330.html
关于: Optimizing simple, targeted review involving priority symptoms and also considerations throughout recurrent and/or metastatic squamous mobile carcinoma with the neck and head: Written content validation from the Useful Evaluation associated with Cancers Therapy/National Thorough Most cancers Community Neck and head Sign Index-10 (FHNSI-10).

drawsign61 的动态

目前积分: 100 分 (积分排名:19)
提问数: 0
回答: 0
评论: 0
投票给了: 0 问题, 0 回答
给出的评价: 0 赞成, 0 反对
收到的评价: 0 赞成, 0 反对

drawsign61 的墙

登录 或者 注册 后再发此贴。
...